학술논문
Five-year results of a phase 2 trial using ipilimumab (I), nivolumab (N), and trabectedin (T) for previously untreated advanced soft tissue sarcoma (NCT03138161).
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
15277755